Amunix Pharmaceuticals, Inc. – Trademark Portfolio
Entity Type: 03
Amunix Pharmaceuticals, Inc. holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 5 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 3 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include XPAC, XPAT, AMUNIX, and PRO-XTEN. The owner is based in South San Francisco, CA.
2 Tower Pl, #1100
South San Francisco, CA 94080
Showing of trademarks Trademarks
Trademark Classifications
Amunix Pharmaceuticals, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Amunix Pharmaceuticals, Inc. have?
Amunix Pharmaceuticals, Inc. has 6 U.S. trademarks filed with the USPTO. Of these, 4 registered, 1 abandoned, 1 cancelled.
What trademark classes does Amunix Pharmaceuticals, Inc. file in?
Amunix Pharmaceuticals, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are Amunix Pharmaceuticals, Inc.'s most well-known trademarks?
Amunix Pharmaceuticals, Inc.'s registered trademark portfolio includes well-known marks such as XPAC, XPAT, AMUNIX, and PRO-XTEN. These are among 4 currently registered trademarks in the portfolio.
What is Amunix Pharmaceuticals, Inc.'s trademark registration success rate?
Amunix Pharmaceuticals, Inc. has a 67% trademark registration rate, with 4 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.